MYLAN 2302 MYLAN 2302 (Prazosin Hydrochloride 2 mg)

Pill with imprint MYLAN 2302 MYLAN 2302 is Brown / Beige, Capsule-shape and has been identified as Prazosin Hydrochloride 2 mg. It is supplied by Mylan Pharmaceuticals Inc..

Prazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; heart failure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Prazosin 2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 2302 MYLAN 2302

Prazosin Hydrochloride

Imprint:

MYLAN 2302 MYLAN 2302

Strength:

2 mg

Color:

Brown / Beige

Size:

18.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Antiadrenergic agents, peripherally acting

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Mylan Pharmaceuticals Inc.

Inactive Ingredients:

• silicon dioxide
• lactose monohydrate
• magnesium stearate
• microcrystalline cellulose
• ferrosoferric oxide
• gelatin
• ferric oxide red
• titanium dioxide
• ferric oxide yellow
• D&C Red No. 28
• D&C Yellow No. 10
• FD&C Blue No. 1
• FD&C Red No. 40
• ammonia
• propylene glycol
• shellac
• dimethicone

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC Code	Labeler / Repackager
00378-2302	Mylan Pharmaceuticals Inc.
51079-0631	UDL Laboratories Inc.
54569-2583	A-S Medication Solutions, LLC (repackager)

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer